Baxter Bros’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Baxter Bros's ELV Position: Q3 2026 in Review
Baxter Bros held its Elevance Health (ELV) position steady in Q3 2026 at 617 shares worth $240K. The position accounts for 0.03% of the portfolio, ranked #160.
Baxter Bros first reported a position in ELV in Q3 2023 and has held it in 10 quarters since. The position peaked at $679K in Q1 2024. 1,385 funds tracked by Wall St. Rank hold ELV as of Q3 2026.
- Baxter Bros held 617 shares of Elevance Health worth $240K as of Q3 2026.
- Baxter Bros left its Elevance Health share count unchanged in Q3 2026.
- Elevance Health made up 0.03% of Baxter Bros's portfolio in Q3 2026, its #160 holding.
- Baxter Bros first reported a position in Elevance Health in Q3 2023 and has held it in 10 quarters since.
- Baxter Bros's Elevance Health position peaked at $679K in Q1 2024.
- 1,385 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.
Based on Baxter Bros's 13F filing for Q3 2026, filed 4 Nov 2026.